Adaptin Bio (APTN) Other financing activities (2024 - 2026)

Adaptin Bio has disclosed Other financing activities across 3 years of filings, most recently posting $121160.0 for Q1 2026.

• Quarterly Other financing activities fell 90.43% year-over-year to $121160.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $858323.0 (changed N/A YoY) and the FY2025 annual result came in at $1.7 million, up 768.35% from the prior year.
• Other financing activities eased to $121160.0 in Q1 2026, from $417038.0 in the prior quarter.
• Across five years, Other financing activities topped out at $1.3 million in Q1 2025 and bottomed at $66366.0 in Q4 2024.
• The 3-year median for Other financing activities is $320125.0 (2025), against an average of $438234.8.
• Year-over-year, Other financing activities jumped 528.39% in 2025 and sank 90.43% in 2026.
• Adaptin Bio's Other financing activities stood at $66366.0 in 2024, then jumped by 528.39% to $417038.0 in 2025, then plunged by 70.95% to $121160.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $121160.0, $417038.0, and $320125.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.